IPO Review: Glenmark Life Sciences Ltd
Moneylife Digital Team 28 July 2021
Glenmark Life Sciences Ltd (GLSL) is a developer and manufacturer of active pharmaceutical ingredients (APIs) in chronic therapeutic areas, including cardiovascular disease (CVS), central nervous system disease (CNS), pain management and diabetes. It also manufactures and sells APIs for gastro-intestinal disorders, anti-infectives and other therapeutic areas. It has a strong market share in...
Premium Content
This is a premium article. Your annual or monthly subscription will not give you access if it is outside your subscription period. You can buy it individually
Pay Per Article Gift An Article
Subscriptions
Access will cover your subscription period. Archives not included. Articles outside the subscription period can be bought individually.
Yearly Digital Access Monthly Digital Access
Already a subscriber ? Log in
Max Ventures: A Special Situations Opportunity?
Moneylife Digital Team 27 July 2021
Max Ventures and Industries Ltd (MVIL) operates across two primary business verticals of real estate and specialty packaging films through its subsidiary companies: Max Estates Ltd, Max Asset Services Ltd, Max I Ltd and Max...
Jubilant Pharmova: Strong Showing in June Quarter
Moneylife Digital Team 27 July 2021
Jubilant Pharmova Ltd (JPL) delivered a growth of 3% q-o-q (quarter-on-quarter) in revenue in Q1FY21-22 due to gradual recovery in all segments. Operating profit remained flat q-o-q at Rs375 crore with operating margins at 23%, as...
Free Helpline
Legal Credit
Feedback